Work

A novel CRLF2-targeted antibody-drug conjugate exhibits potent anti-leukemic activity against Ph-like acute lymphoblastic leukemia

Year: 2026

Type: article

Source: Leukemia

DOI: 10.1038/s41375-026-02976-5

Authors: Sara M. A. Mohamed, Peter Schofield, Kathryn Evans, Karl-Heinz Friedrich, Daniel Christ, Narges Bayat, Richard B. Lock

Institutions: Ain Shams University, UNSW Sydney, Garvan Institute of Medical Research, Jena University Hospital, Children's Cancer Institute Australia

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Health and Medical Research Council

OpenAlex ID: W7160335249

FWCI:

Cites: 15

Cited by:

Related to: 10